Published on
For the second year in a row, CHOP has been recognized as an LGBT Healthcare Equality Leader by the country’s largest lesbian, gay, bisexual and transgender (LGBT) civil rights organization.
Published on
CHOP researchers have identified a powerful new drug with “unparalleled” strength against refractory types of neuroblastoma.
Published on
Emily Whitehead and her family presented CHOP with $100,000 which will go directly to a new clinical trial testing the treatment Emily received on other types of cancer.
Published on
The Children's Hospital of Philadelphia’s Division of Pediatric Ophthalmology welcomes neuro-ophthalmologist Robert A. Avery, DO, MSCE.
Published on
Spark Therapeutics, Inc. recently announced a public offering issuing two-million primary shares at $47.00 per share. Included in the sale as a secondary offering are one-million shares, at $47.00, held by CHOP.
Published on
An international survey finds gap in knowledge when dealing with child traumatic stress.
Published on
The Children’s Hospital of Philadelphia has chosen Douglas G. Hock as its new executive vice president and chief operating officer, beginning on Feb. 1.
Published on
Tamron Hall, co-anchor of the Today Show, recently honored HHI Program Director Karen Hudson with a surprise as part of the show’s “Pay It Forward” holiday series.
Published on
Should short, healthy children receive human growth hormone? CHOP researchers focused directly on parents’ concerns and decision-making.
Published on
The Children’s Hospital of Philadelphia received a $333,648 donation from Kohl's, through its Kohl’s Cares program, to support the hospital’s injury prevention programs.